Other HDAC inhibitors (HDACi), including SL142, SL325 [82], HTPB [83], and CG0006 [13], have shown promise in inducing apoptosis and inhibiting the proliferation of NSCLC cells. Here, HDAC9 is linked to non-small cell lung carcinoma.